DEF 14AThe Ballot
BIOCRYST PHARMACEUTICALS INC files DEF 14A
Filed Apr 25, 2024 · 2y ago · Accession 0001628280-24-018175
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- DEF 14A
- Filing date
- Apr 25, 2024
- Report date
- Jun 12, 2024
- Document
- bcrx-20240425.htm
- Size
- 3.2 MB